What is a stock summary page? Click here for an overview.
Business Description
Description
Mahachai Hospital PCL is a Thailand-based company offering medical services. It operates in the hospital and medical trading business. The company is engaged in operating a private hospital under the name of Mahachai Hospital. It offers various medical services, including a urology clinic, blood and cancer clinic, surgery, obstetrics and gynecology, ear, nose, and throat clinic, general clinic, dental and implants center, skin and beauty center, and physical department. The Group operates in Thailand only.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 |
N/A
|
N/A
| |||
Equity-to-Asset | 0.19 |
N/A
|
N/A
| |||
Debt-to-Equity | 3.3 |
N/A
|
N/A
| |||
Debt-to-EBITDA | 6.19 |
N/A
|
N/A
| |||
Interest Coverage | 0.99 |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.95 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.2 | |||||
3-Year EBITDA Growth Rate | 1.8 |
N/A
|
N/A
| |||
3-Year EPS without NRI Growth Rate | -42.9 |
N/A
|
N/A
| |||
3-Year Book Growth Rate | 4.9 |
N/A
|
N/A
|
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.62 |
N/A
|
N/A
| |||
9-Day RSI | 41.93 |
N/A
|
N/A
| |||
14-Day RSI | 35.29 |
N/A
|
N/A
| |||
3-1 Month Momentum % | -22.69 |
N/A
|
N/A
| |||
6-1 Month Momentum % | -35.68 |
N/A
|
N/A
| |||
12-1 Month Momentum % | -64.27 |
N/A
|
N/A
|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.48 |
N/A
|
N/A
| |||
Quick Ratio | 0.43 |
N/A
|
N/A
| |||
Cash Ratio | 0.06 |
N/A
|
N/A
| |||
Days Inventory | 12.38 |
N/A
|
N/A
| |||
Days Sales Outstanding | 58.91 |
N/A
|
N/A
| |||
Days Payable | 20.89 |
N/A
|
N/A
|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.35 |
N/A
|
N/A
| |||
Dividend Payout Ratio | 1.56 |
N/A
|
N/A
| |||
3-Year Dividend Growth Rate | 51.8 |
N/A
|
N/A
| |||
Forward Dividend Yield % | 1.35 |
N/A
|
N/A
| |||
5-Year Yield-on-Cost % | 4.17 |
N/A
|
N/A
| |||
Shareholder Yield % | 3.21 |
N/A
|
N/A
|
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 19.63 |
N/A
|
N/A
| |||
Operating Margin % | 5.73 |
N/A
|
N/A
| |||
Net Margin % | 1.08 |
N/A
|
N/A
| |||
FCF Margin % | 5.7 |
N/A
|
N/A
| |||
ROE % | 3.18 |
N/A
|
N/A
| |||
ROA % | 0.6 |
N/A
|
N/A
| |||
ROIC % | 2.47 |
N/A
|
N/A
| |||
3-Year ROIIC % | 24.71 |
N/A
|
N/A
| |||
ROC (Joel Greenblatt) % | 4.61 |
N/A
|
N/A
| |||
ROCE % | 4.75 |
N/A
|
N/A
| |||
Years of Profitability over Past 10-Year | 10 |
N/A
|
N/A
|
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 41.42 |
N/A
|
N/A
| |||
PE Ratio without NRI | 41.42 |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 102.19 |
N/A
|
N/A
| |||
PEG Ratio | 1.05 |
N/A
|
N/A
| |||
PS Ratio | 0.45 |
N/A
|
N/A
| |||
PB Ratio | 1.34 |
N/A
|
N/A
| |||
Price-to-Tangible-Book | 1.39 |
N/A
|
N/A
| |||
Price-to-Free-Cash-Flow | 7.88 |
N/A
|
N/A
| |||
Price-to-Operating-Cash-Flow | 5.03 |
N/A
|
N/A
| |||
EV-to-EBIT | 25.47 |
N/A
|
N/A
| |||
EV-to-EBITDA | 9.4 |
N/A
|
N/A
| |||
EV-to-Revenue | 1.69 |
N/A
|
N/A
| |||
EV-to-FCF | 29.65 |
N/A
|
N/A
| |||
Price-to-GF-Value | 0.41 |
N/A
|
N/A
| |||
Price-to-DCF (Earnings Based) | 3.59 |
N/A
|
N/A
| |||
Price-to-DCF (FCF Based) | 0.68 |
N/A
|
N/A
| |||
Price-to-Median-PS-Value | 0.35 |
N/A
|
N/A
| |||
Price-to-Peter-Lynch-Fair-Value | 1.66 |
N/A
|
N/A
| |||
Price-to-Graham-Number | 1.6 |
N/A
|
N/A
| |||
Earnings Yield (Greenblatt) % | 3.93 |
N/A
|
N/A
| |||
FCF Yield % | 12.77 |
N/A
|
N/A
| |||
Forward Rate of Return (Yacktman) % | 1.94 |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mahachai Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ฿) | 6,629.69 | ||
EPS (TTM) (฿) | 0.45 | ||
Beta | 1.13 | ||
3-Year Sharpe Ratio | -0.15 | ||
3-Year Sortino Ratio | -0.24 | ||
Volatility % | 28.28 | ||
14-Day RSI | 35.29 | ||
14-Day ATR (฿) | 0.35 | ||
20-Day SMA (฿) | 18.78 | ||
12-1 Month Momentum % | -64.27 | ||
52-Week Range (฿) | 18 - 58.75 | ||
Shares Outstanding (Mil) | 160 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mahachai Hospital PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mahachai Hospital PCL Stock Events
Event | Date | Price (฿) | ||
---|---|---|---|---|
No Event Data |
Mahachai Hospital PCL Frequently Asked Questions
What is Mahachai Hospital PCL(BKK:M-CHAI)'s stock price today?
The current price of BKK:M-CHAI is ฿18.60. The 52 week high of BKK:M-CHAI is ฿58.75 and 52 week low is ฿18.00.
When is next earnings date of Mahachai Hospital PCL(BKK:M-CHAI)?
The next earnings date of Mahachai Hospital PCL(BKK:M-CHAI) is .
Does Mahachai Hospital PCL(BKK:M-CHAI) pay dividends? If so, how much?
The Dividend Yield %  of Mahachai Hospital PCL(BKK:M-CHAI) is 1.35% (As of Today), Highest Dividend Payout Ratio of Mahachai Hospital PCL(BKK:M-CHAI) was 1.56. The lowest was 0.08. And the median was 0.44. The  Forward Dividend Yield % of Mahachai Hospital PCL(BKK:M-CHAI) is 1.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |